PREVENTABLE Project Showcased at ESHG 2024: Focus on Li-Fraumeni
The PREVENTABLE project was recently presented at the 57th Conference of the European Society of Human Genetics (ESHG) in Berlin, Germany, held from June 1-4, 2024. The e-poster session was led by CHU & CHB Rouen, showcasing the project’s significant progress on Li-Fraumeni Syndrome (LFS), one of the eight Rare Tumor Risk Syndromes (RTRS) addressed by the initiative.
The ESHG conference is a premier international event that gathers around 5,000 participants, including scientific researchers, engineers, clinical and molecular geneticists, cytogeneticists, nurses, genetic counsellors, bioinformaticians, and professionals from various multidisciplinary fields. This diverse gathering fosters research, promotes best practices, and facilitates communication within the field of human and medical genetics in Europe. Such a comprehensive audience allows for complex issues to be addressed from multiple perspectives, working collectively towards shared goals in genetics.
The presentation, titled “Li-Fraumeni Syndrome: Pathways of Care for Cancer Prevention versus Cancer Treatment,” highlighted the PREVENTABLE project’s efforts to refine care pathways for patients with LFS. The CHU & CHB team from Rouen shared their expertise in developing a matrix comprising six clinical modules with sub-procedures tailored to the different care pathways available to LFS patients. The session underscored the importance of creating personalized care strategies to manage the high cancer risks associated with this hereditary condition.
Claude Houdayer, a key participant in this event, emphasized the value of the presentation in disseminating the Rouen team’s knowledge and advancing the conversation on LFS management. The insights presented at ESHG 2024 underscore the ongoing commitment of the PREVENTABLE project to improving patient outcomes and developing innovative strategies for managing rare genetic disorders.
Do you want to learn more about the research? Download the poster below
